Shares of Presbia PLC (NASDAQ:LENS) hit a new 52-week low on Friday . The company traded as low as $0.52 and last traded at $0.58, with a volume of 48433 shares. The stock had previously closed at $0.65.

A number of analysts have recently weighed in on LENS shares. HC Wainwright restated a “buy” rating and issued a $6.00 price objective on shares of Presbia in a research note on Monday, August 27th. Zacks Investment Research upgraded shares of Presbia from a “sell” rating to a “hold” rating in a research note on Thursday, September 27th.

ILLEGAL ACTIVITY NOTICE: “Presbia (LENS) Sets New 52-Week Low at $0.52” was first published by Watch List News and is owned by of Watch List News. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at

About Presbia (NASDAQ:LENS)

Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in South Korea, Australia, New Zealand, Italy, the Netherlands, Ireland, Canada, and Germany.

Read More: How is inflation measured?

Receive News & Ratings for Presbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia and related companies with's FREE daily email newsletter.